Clinical trial
Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
NCT00548912
Study timeline
Study start (actual)2007-10-01Date precision: month
Registry last updated2021-12-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Kidney Failure, Chronicunresolved
Interventions
SpironolactoneDRUG · verified · RxNorm: spironolactone
Sponsors & collaborators
Dawnmarie DeFaziolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00548912 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.